Detalhe da pesquisa
1.
Effects on bone by the light/dark cycle and chronic treatment with melatonin and/or hormone replacement therapy in intact female mice.
J Pineal Res
; 53(4): 374-84, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22639972
2.
N-Acetyl-5-arylalkoxytryptamine analogs: probing the melatonin receptors for MT(1) -selectivity.
Arch Pharm (Weinheim)
; 344(10): 666-74, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21887801
3.
Determination of the minimal melatonin exposure required to induce osteoblast differentiation from human mesenchymal stem cells and these effects on downstream signaling pathways.
J Pineal Res
; 49(3): 222-38, 2010 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-20626586
4.
Synthesis and pharmacological evaluation of 1,2,3,4-tetrahydropyrazino[1,2-a]indole and 2-[(phenylmethylamino)methyl]-1H-indole analogues as novel melatoninergic ligands.
Bioorg Med Chem
; 17(13): 4583-94, 2009 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19473848
5.
Co-administering Melatonin With an Estradiol-Progesterone Menopausal Hormone Therapy Represses Mammary Cancer Development in a Mouse Model of HER2-Positive Breast Cancer.
Front Oncol
; 9: 525, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31355130
6.
C-terminal domains within human MT1 and MT2 melatonin receptors are involved in internalization processes.
J Pineal Res
; 45(2): 212-8, 2008 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-18341518
7.
Role for immunotherapy in pretreated, recurrent, metastatic squamous cell carcinoma arising from mature cystic teratoma.
Gynecol Oncol Rep
; 47: 101181, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37077325
8.
2-[(2,3-dihydro-1H-indol-1-yl)methyl]melatonin analogues: a novel class of MT2-selective melatonin receptor antagonists.
J Med Chem
; 52(3): 826-33, 2009 Feb 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-19193160